Search Results - "Prusty, Pitambar"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the East India cohort of the A 1 chieve study by Sahoo, AbhayKumar, Das, Sambit, Prusty, Pitambar, Shankar, Anand, Guha, Shaibal

    “…Background: The A1chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic…”
    Get full text
    Journal Article
  2. 2

    Resistant prolactinoma: Is it monoclonal or polyclonal? by Kumar, K V S Hari, Prusty, Pitambar

    “…Prolactinomas are solitary benign neoplasms and resistance to dopamine agonists occur in a small percentage of prolactinomas. Multiple pituitary adenomas are…”
    Get full text
    Journal Article
  3. 3

    Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: A randomized, open label study by Hari Kumar, K.V.S, Shaikh, Altamash, Prusty, Pitambar

    Published in Diabetes research and clinical practice (01-05-2013)
    “…Abstract Incretin based therapies are known to have pleotropic benefits in type 2 diabetes but have not been studied in new onset type 1 diabetes. In this…”
    Get full text
    Journal Article
  4. 4

    Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the East India cohort of the A1chieve study by Sahoo, Abhay Kumar, Das, Sambit, Prusty, Pitambar, Shankar, Anand, Guha, Shaibal

    “…The A1chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin…”
    Get full text
    Journal Article
  5. 5

    Diabetes in young--unusual case presentation by Kumar, K V S Hari, Priya, Sai, Shaikh, Altamash, Prusty, Pitambar

    “…Diabetes in young is increasing in prevalence with each decade. Phenotypic features like obesity and acanthosis nigricans characterize type 2 diabetes, whereas…”
    Get more information
    Journal Article
  6. 6

    Resistant prolactinoma: Is it monoclonal or polyclonal? by Kumar, K V S Hari, Prusty, Pitambar

    “…Prolactinomas are solitary benign neoplasms and resistance to dopamine agonists occur in a small percentage of prolactinomas. Multiple pituitary adenomas are…”
    Get full text
    Report
  7. 7